Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| May 7th, 2023 |
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2023 |
Small R01s for Clinical Trials Targeting Diseases within the Mission of NIDDK (R01 Clinical Trial Required) |
National Institutes of Health |
| May 7th, 2023 |
Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01 Clinical Trial Optional) |
National Institutes of Health |
| September 7th, 2022 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2023 |
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required) |
National Institutes of Health |
| July 13th, 2022 |
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed) |
National Institutes of Health |
| May 28th, 2020 |
USAID Zambia Accessible Markets for Health (ZAM-Health) Activity |
Zambia USAID Lusaka |
| April 20th, 2020 |
Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) |
National Institutes of Health |
| April 30th, 2020 |
Aging and Disability Resource Center/No Wrong Door System Funding Opportunity: Critical Relief Funds for COVID-19 Pandemic Response |
Administration for Community Living |
| September 28th, 2020 |
Tuberculosis Research Units (U19 Clinical Trial Optional) |
National Institutes of Health |
| June 17th, 2020 |
Fiscal Year (FY) 2020 Targeted Violence and Terrorism Prevention (TVTP) Program |
Department of Homeland Security FEMA |
| April 10th, 2020 |
Strengthening Federal Ministry of Health Capabilities in Technical Assistance for Service Delivery and Execution of Core Public Health Functions to Achieve and Sustain HIV Epidemic Control in Ethiopia, under PEPFAR |
Centers for Disease Control CGH |
| May 19th, 2020 |
State Opioid Response Grants |
Substance Abuse and Mental Health Services Adminis |
| May 7th, 2023 |
NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) |
National Institutes of Health |
| June 18th, 2020 |
Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional) |
National Institutes of Health |
| May 7th, 2023 |
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R21- Clinical Trial Not Allowed) |
National Institutes of Health |
| May 7th, 2023 |
Extracellular RNA carrier subclasses in processes relevant to Substance Use Disorders or HIV infection (R01- Clinical Trial Not Allowed) |
National Institutes of Health |
| August 13th, 2021 |
Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional) |
National Institutes of Health |
| April 3rd, 2020 |
Hospital Association COVID-19 Preparedness and Response Activities |
Assistant Secretary for Preparedness and Response |
| June 12th, 2020 |
Strengthening Access to and Delivery of Quality Public Health Services for Prevention, Care and Treatment of HIV, STIs, and TB, Addressing Diseases of Public Health Importance, and Advancing Global Health Security in |
Centers for Disease Control CGH |
|
| May 7th, 2023 |
NIDA Small Research Grant Program (R03 Clinical Trial Required) |
National Institutes of Health |
| April 1st, 2020 |
COVID-19 Response Supplement: Tribal Public Health Capacity-Building and Quality Improvement Umbrella Cooperative Agreement. |
Centers for Disease Control OSTLTS |
| July 28th, 2020 |
Long Acting Treatments for HIV and HIV-Associated Co-Infections (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
| June 28th, 2020 |
Special Topic Research Education Course: Exploring Auditory and Vestibular Biology (R25 - Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2023 |
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2023 |
Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) |
National Institutes of Health |
| July 7th, 2020 |
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Coordinating Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| July 7th, 2020 |
Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry Centers (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| August 28th, 2020 |
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) |
National Institutes of Health |
| May 19th, 2020 |
Protecting and Improving Public Health in Pakistan: Strengthening and Sustaining Public Health Impact, Systems, Capacity, and Security |
Centers for Disease Control CGH |
| May 25th, 2023 |
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) |
National Institutes of Health |
| June 30th, 2020 |
Strengthening environmental health capacity (EHC) to detect, prevent, and control environmental health hazards through data-driven, evidence-based approaches |
Centers for Disease Control NCEH |
| July 30th, 2020 |
Genomic Predictors of Pregnancy Loss (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 4th, 2022 |
Novel Synthetic Nucleic Acid Technology Development (R43/R44)( Clinical Trial not allowed) |
National Institutes of Health |
| February 4th, 2022 |
Novel Synthetic Nucleic Acid Technology Development (R01 Clinical Trial not allowed) |
National Institutes of Health |
| May 15th, 2020 |
Firearm Injury and Mortality Prevention Research (R61 Clinical Trial Optional) |
National Institutes of Health |
| January 7th, 2023 |
Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) |
National Institutes of Health |
| February 4th, 2022 |
Novel Synthetic Nucleic Acid Technology Development (R21 Clinical Trial not allowed) |
National Institutes of Health |
| May 18th, 2020 |
BJA FY 20 The Justice and Mental Health Collaboration Program |
Bureau of Justice Assistance |
| May 20th, 2020 |
American Schools and Hospitals Abroad Program Worldwide |
Agency for International Development |
